Nature's Sunshine(NATR) - 2025 Q3 - Quarterly Results

Financial Performance - Net sales increased by 12% to $128.3 million compared to $114.6 million in the same quarter last year[3] - Adjusted EBITDA rose by 42% to $15.2 million, up from $10.7 million in the prior year[10] - Gross profit margin improved by 200 basis points to 73.3%, the highest level in 15 quarters[5] - Full-year net sales outlook raised to a range of $476 - $480 million, up from $460 - $475 million[13] - GAAP net income attributable to common shareholders increased to $5.3 million, or $0.30 per diluted share, compared to $4.3 million, or $0.23 per diluted share, in the prior year[9] - Operating income increased to $9.0 million, or 7.0% of net sales, compared to $5.3 million, or 4.6% of net sales, in the year-ago quarter[7] - Net income attributable to common shareholders for the nine months ended September 30, 2025, was $15,414 million, more than doubling from $8,017 million in the same period of 2024[35] - Basic earnings per share attributable to common shareholders increased to $0.30 in Q3 2025 from $0.23 in Q3 2024, a rise of 30.4%[35] Sales and Growth - Digital sales surged by 52% year-over-year, driven by new customer acquisition and strong retention[2] - Asia-Pacific region saw over 30% growth in both Japan and China during the quarter[2] - Net sales for Q3 2025 reached $128,339 million, a 12% increase from $114,615 million in Q3 2024[27] - Gross profit for the nine months ended September 30, 2025, was $257,945 million, up from $239,624 million in the same period of 2024, reflecting a growth of 7.6%[27] - Operating income for Q3 2025 was $8,975 million, compared to $5,284 million in Q3 2024, representing a significant increase of 70.5%[27] Cash Flow and Assets - Net cash provided by operating activities for the nine months ended September 30, 2025, was $25.4 million, compared to $13.1 million in the prior year[11] - Total current assets as of September 30, 2025, were $186,084 million, up from $160,579 million at the end of 2024, indicating a growth of 15.9%[29] - Cash and cash equivalents at the end of Q3 2025 were $95,554 million, an increase from $84,700 million at the beginning of the period, reflecting a growth of 12.2%[31] Expenses and Liabilities - Selling, general and administrative expenses (SG&A) were $45.7 million, representing 35.6% of net sales, a slight decrease from 35.7% in the previous year[6] - Total liabilities increased to $98,101 million as of September 30, 2025, compared to $79,864 million at the end of 2024, marking a rise of 22.7%[29] Non-GAAP Measures - Adjusted EBITDA for the nine months ended September 30, 2025, was $37,421 million, compared to $30,277 million in the same period of 2024, representing a growth of 23.4%[33] - Non-GAAP net income attributable to common shareholders for the nine months ended September 30, 2025, was $17,843 million, up from $8,819 million in the same period of 2024, indicating a substantial increase of 101.5%[35]